Clinical Trial: Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma

Brief Summary: Consolidation treatment for Primary Central Nervous System Diffuse Large B cell Lymphoma(PCNSL)patients remains to be defined.Here we designed a tolerated treatment of HDMTX plus Temozolomide,followed by consolidation with Temozolomide in PCNSL patients.